Stomach Neoplasms: all 2,914 studies
Page 28 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric CancerCompletedNCT00611507Phase 2
- Effects of Early Oral Feeding After Resection of Gastric CancerCompletedNCT00606619Phase 3
- Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach CancerCompletedNCT00601510Phase 1
- Quality of Life Among Long-Term Survivors of Resected Gastric CancerCompletedNCT00598546
- The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric CancerCompletedNCT00596401
- Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric CancerTerminatedNCT00595985Phase 2
- Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric CancerCompletedNCT00595972Phase 2
- Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric CancerStatus unknownNCT00591045Phase 2
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric CancerStatus unknownNCT00587145Phase 2
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractActive, not recruitingNCT00582647
- Early Onset and Familial Gastric Cancer RegistryCompletedNCT00582257
- S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric CancerStatus unknownNCT00580359Phase 2
- Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal TumorsCompletedNCT00580281Not applicable
- Study of Weekly DCF to Treat Advanced Gastric CancerTerminatedNCT00568971Phase 2
- Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric CancerSuspendedNCT00568529Phase 2
- Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue SampleCompletedNCT00568438
- Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer SurgeryTerminatedNCT00560846Not applicable
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2
- Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301)CompletedNCT00546468Phase 3
- Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerCompletedNCT00544193Phase 1
- Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal SeedingCompletedNCT00539877Phase 1
- Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
- A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerCompletedNCT00533533Phase 1/2
- Bioresorbable Membrane to Reduce Postoperative Small Bowel ObstructionCompletedNCT00529412Phase 3
- Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric CancerCompletedNCT00525005Phase 2
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerTerminatedNCT00524186Phase 1
- Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric CancerCompletedNCT00519324Phase 2
- Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric CarcinomaStatus unknownNCT00515190Phase 2
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerCompletedNCT00512681Phase 2
- Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE)CompletedNCT00512304Phase 2
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerCompletedNCT00511446Phase 2
- Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGCStatus unknownNCT00510107Phase 2
- Second-Line Irinotecan vs. ILF for AGCStatus unknownNCT00509964Phase 2
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyStatus unknownNCT00506207Phase 1
- Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric CarcinomaTerminatedNCT00503321Phase 2/3
- Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer PatientsCompletedNCT00502502
- Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase PathwayStatus unknownNCT00498134Not applicable
- Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderCompletedNCT00489515
- Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
- Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach CancerCompletedNCT00477880Phase 1
- A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00477711Phase 2
- Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
- Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative ResectionCompletedNCT00464893Phase 2
- Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal CarcinomatosisStatus unknownNCT00454519Phase 2
- Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized TrialStatus unknownNCT00452751Phase 3
- Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric PatientsCompletedNCT00447967Phase 2
- A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled TrialStatus unknownNCT00447746Not applicable
- A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.CompletedNCT00436241Phase 2
- Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
- Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric CancerWithdrawnNCT00429078Phase 1
- Perioperative Chemoradiotherapy for Potentially Resectable Gastric CancerStatus unknownNCT00420394Phase 2
- Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and PancreasStatus unknownNCT00419627
- Capecitabine and Oxaliplatin Adjuvant Study in Stomach CancerCompletedNCT00411229Phase 3
- Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)Active, not recruitingNCT00407186Phase 3
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Chemoradiation-Induced Nausea and Emesis: Quality of LifeTerminatedNCT00394602
- Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive CancerWithdrawnNCT00387530Phase 2
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric CancerStatus unknownNCT00384878Phase 2
- Zinc Supplements in Lowering Cadmium Levels in SmokersCompletedNCT00376987Phase 2
- Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal JunctionCompletedNCT00374985Phase 1/2
- Metastatic Gastric Cancer FFCD 03-07CompletedNCT00374036Phase 3
- Velcade in MALT Lymphoma PatientsCompletedNCT00373906Phase 2
- A Study of Vinflunine in Patients With Gastric CancerTerminatedNCT00359476Phase 2/3
- Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric AdenocarcinomaCompletedNCT00352833Phase 2
- S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric CancerStatus unknownNCT00343668Phase 2
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- Nutrition Intervention Trials in Linxian Follow-up StudyCompletedNCT00342654
- A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among WomenCompletedNCT00342004
- Early Detection of Esophageal CancerTerminatedNCT00341523
- Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeCompletedNCT00327132Not applicable
- Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaCompletedNCT00323830Phase 3
- ILF With/Without Cisplatin for Advanced Gastric CancerStatus unknownNCT00320294Phase 2
- Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric CancerCompletedNCT00313872Phase 3
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
- Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing CancersCompletedNCT00291473Phase 1
- Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCompletedNCT00290966Phase 2/3
- Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric CancerCompletedNCT00287768Phase 3
- Clinical Trial of Chemosensitivity TestCompletedNCT00287755Phase 2
- Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric CancerCompletedNCT00275951Phase 2
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric CancerStatus unknownNCT00270543Phase 2
- Oxaliplatin in Gastric CancerCompletedNCT00263354Phase 2
- Phase III Study OF the Gastric Surgery on Advanced Stage Gastric CancerCompletedNCT00260884Phase 3
- Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction CarcinomaTerminatedNCT00256321Phase 2
- A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric CancerCompletedNCT00252161Phase 3
- Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTerminatedNCT00237900Phase 1/2
- Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSKCompletedNCT00216034Phase 3
- Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasCompletedNCT00215995Phase 2
- Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00215514Early Phase 1
- Vinorelbine in Unresectable or Metastatic Esophageal and Gastric AdenocarcinomaCompletedNCT00215462Phase 2
- Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.SuspendedNCT00209729Phase 1/2
- Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric CancerSuspendedNCT00209664Phase 2
- Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric CancerCompletedNCT00209638Phase 1/2
- Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.WithdrawnNCT00209612Phase 1/2
- Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerCompletedNCT00202969Phase 3
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerCompletedNCT00201747Phase 2
- Cytokine Gene Polymorphisms in Gastric DiseasesStatus unknownNCT00197470Not applicable
- Study Evaluating Isovorin in Advanced/Recurrent Gastric CancerCompletedNCT00195572Phase 3
- A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCompletedNCT00192088Phase 2